Related Experiment Videos
Fatal reactions to intravenous nonionic contrast material
N S Curry1, S I Schabel, C T Reiheld
1Department of Radiology, Medical University of South Carolina, Charleston 29425.
Radiology
|February 1, 1991
Summary
Low-osmolality contrast media (LOCM) reduce side effects but may not lower death rates compared to high-osmolality agents. Universal conversion to LOCM could incur significant costs without clear lifesaving benefits.
Area of Science:
- Radiology
- Medical Imaging
- Patient Safety
Background:
- Contrast media are essential in medical imaging for enhancing visualization.
- Low-osmolality contrast media (LOCM) were developed to minimize adverse reactions compared to older high-osmolality contrast agents (HOCM).
- The clinical benefits and safety profile of LOCM require ongoing evaluation.
Observation:
- Three fatalities were reported in association with the use of LOCM.
- While LOCM demonstrably reduce patient discomfort and severe reactions.
- Current data are insufficient to definitively compare mortality rates between LOCM and HOCM.
Findings:
- Adverse events, including fatalities, can occur even with LOCM.
- The reduction in side effects with LOCM is well-established.
- Comparative mortality data between LOCM and HOCM remain inconclusive.
Implications:
- Widespread adoption of LOCM may lead to substantial healthcare costs.
- The cost-effectiveness of universal LOCM adoption requires further investigation.
- Careful patient selection and monitoring remain crucial regardless of contrast agent osmolality.